nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—type 2 diabetes mellitus—atherosclerosis	0.517	1	CtDrD
Glipizide—PPARG—atherosclerosis	0.231	1	CbGaD
Glipizide—CYP2C9—Rosuvastatin—atherosclerosis	0.0205	0.154	CbGbCtD
Glipizide—CYP2C9—Simvastatin—atherosclerosis	0.0191	0.143	CbGbCtD
Glipizide—CYP2C9—Pravastatin—atherosclerosis	0.0187	0.14	CbGbCtD
Glipizide—CYP2C9—Lovastatin—atherosclerosis	0.0187	0.14	CbGbCtD
Glipizide—CYP3A4—Rosuvastatin—atherosclerosis	0.0119	0.0893	CbGbCtD
Glipizide—CYP3A4—Ezetimibe—atherosclerosis	0.0119	0.0893	CbGbCtD
Glipizide—CYP3A4—Simvastatin—atherosclerosis	0.0111	0.083	CbGbCtD
Glipizide—CYP3A4—Pravastatin—atherosclerosis	0.0108	0.0812	CbGbCtD
Glipizide—CYP3A4—Lovastatin—atherosclerosis	0.0108	0.0812	CbGbCtD
Glipizide—ABCC8—penis—atherosclerosis	0.00409	0.218	CbGeAlD
Glipizide—PPARG—leg—atherosclerosis	0.00264	0.141	CbGeAlD
Glipizide—PPARG—hindlimb—atherosclerosis	0.00236	0.126	CbGeAlD
Glipizide—PPARG—appendage—atherosclerosis	0.00202	0.108	CbGeAlD
Glipizide—PPARG—artery—atherosclerosis	0.00145	0.0772	CbGeAlD
Glipizide—PPARG—endothelium—atherosclerosis	0.00122	0.0652	CbGeAlD
Glipizide—PPARG—blood vessel—atherosclerosis	0.00113	0.0601	CbGeAlD
Glipizide—KCNJ11—cardiovascular system—atherosclerosis	0.000715	0.0382	CbGeAlD
Glipizide—ABCC8—cardiovascular system—atherosclerosis	0.000658	0.0351	CbGeAlD
Glipizide—Glyburide—ABCA1—atherosclerosis	0.000609	0.427	CrCbGaD
Glipizide—Gliclazide—VEGFA—atherosclerosis	0.000579	0.406	CrCbGaD
Glipizide—PPARG—connective tissue—atherosclerosis	0.000577	0.0308	CbGeAlD
Glipizide—PPARG—cardiovascular system—atherosclerosis	0.000502	0.0268	CbGeAlD
Glipizide—PPARG—adipose tissue—atherosclerosis	0.000443	0.0237	CbGeAlD
Glipizide—PPARG—liver—atherosclerosis	0.000311	0.0166	CbGeAlD
Glipizide—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000307	0.00463	CcSEcCtD
Glipizide—Jaundice—Ezetimibe—atherosclerosis	0.000306	0.00462	CcSEcCtD
Glipizide—Arrhythmia—Rosuvastatin—atherosclerosis	0.000303	0.00457	CcSEcCtD
Glipizide—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000297	0.00448	CcSEcCtD
Glipizide—CYP2C9—cardiovascular system—atherosclerosis	0.000294	0.0157	CbGeAlD
Glipizide—Jaundice—Simvastatin—atherosclerosis	0.000292	0.00441	CcSEcCtD
Glipizide—Flatulence—Rosuvastatin—atherosclerosis	0.000291	0.00439	CcSEcCtD
Glipizide—Hepatitis—Lovastatin—atherosclerosis	0.000288	0.00434	CcSEcCtD
Glipizide—Dysuria—Pravastatin—atherosclerosis	0.000284	0.00429	CcSEcCtD
Glipizide—Hepatitis—Ezetimibe—atherosclerosis	0.000282	0.00426	CcSEcCtD
Glipizide—Pharyngitis—Ezetimibe—atherosclerosis	0.00028	0.00422	CcSEcCtD
Glipizide—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000277	0.00418	CcSEcCtD
Glipizide—Hepatitis—Simvastatin—atherosclerosis	0.000269	0.00406	CcSEcCtD
Glipizide—Jaundice—Niacin—atherosclerosis	0.000268	0.00405	CcSEcCtD
Glipizide—Flushing—Lovastatin—atherosclerosis	0.000267	0.00403	CcSEcCtD
Glipizide—Jaundice—Pravastatin—atherosclerosis	0.000264	0.00398	CcSEcCtD
Glipizide—Sweating—Niacin—atherosclerosis	0.000264	0.00398	CcSEcCtD
Glipizide—Flushing—Ezetimibe—atherosclerosis	0.000262	0.00395	CcSEcCtD
Glipizide—Chills—Lovastatin—atherosclerosis	0.000258	0.00389	CcSEcCtD
Glipizide—Myalgia—Rosuvastatin—atherosclerosis	0.000252	0.00379	CcSEcCtD
Glipizide—Arthralgia—Rosuvastatin—atherosclerosis	0.000252	0.00379	CcSEcCtD
Glipizide—Flushing—Simvastatin—atherosclerosis	0.00025	0.00377	CcSEcCtD
Glipizide—Rhinitis—Niacin—atherosclerosis	0.000248	0.00374	CcSEcCtD
Glipizide—Hepatitis—Niacin—atherosclerosis	0.000247	0.00373	CcSEcCtD
Glipizide—Flatulence—Lovastatin—atherosclerosis	0.000247	0.00372	CcSEcCtD
Glipizide—Hypoaesthesia—Niacin—atherosclerosis	0.000246	0.00371	CcSEcCtD
Glipizide—Erythema—Ezetimibe—atherosclerosis	0.000246	0.0037	CcSEcCtD
Glipizide—Rhinitis—Pravastatin—atherosclerosis	0.000244	0.00368	CcSEcCtD
Glipizide—Hepatitis—Pravastatin—atherosclerosis	0.000243	0.00367	CcSEcCtD
Glipizide—Confusional state—Rosuvastatin—atherosclerosis	0.000243	0.00367	CcSEcCtD
Glipizide—Hypoaesthesia—Pravastatin—atherosclerosis	0.000242	0.00365	CcSEcCtD
Glipizide—Flatulence—Ezetimibe—atherosclerosis	0.000242	0.00365	CcSEcCtD
Glipizide—Pharyngitis—Pravastatin—atherosclerosis	0.000241	0.00364	CcSEcCtD
Glipizide—Chills—Simvastatin—atherosclerosis	0.000241	0.00364	CcSEcCtD
Glipizide—Muscle spasms—Lovastatin—atherosclerosis	0.000241	0.00363	CcSEcCtD
Glipizide—Visual impairment—Niacin—atherosclerosis	0.000238	0.00359	CcSEcCtD
Glipizide—Muscle spasms—Ezetimibe—atherosclerosis	0.000236	0.00356	CcSEcCtD
Glipizide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000236	0.00356	CcSEcCtD
Glipizide—Vision blurred—Lovastatin—atherosclerosis	0.000236	0.00356	CcSEcCtD
Glipizide—Tremor—Lovastatin—atherosclerosis	0.000235	0.00354	CcSEcCtD
Glipizide—Visual impairment—Pravastatin—atherosclerosis	0.000234	0.00354	CcSEcCtD
Glipizide—Erythema—Simvastatin—atherosclerosis	0.000234	0.00353	CcSEcCtD
Glipizide—Ill-defined disorder—Lovastatin—atherosclerosis	0.000232	0.0035	CcSEcCtD
Glipizide—Eye disorder—Niacin—atherosclerosis	0.000231	0.00348	CcSEcCtD
Glipizide—Flatulence—Simvastatin—atherosclerosis	0.000231	0.00348	CcSEcCtD
Glipizide—Flushing—Niacin—atherosclerosis	0.000229	0.00346	CcSEcCtD
Glipizide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000228	0.00344	CcSEcCtD
Glipizide—Malaise—Lovastatin—atherosclerosis	0.000226	0.00341	CcSEcCtD
Glipizide—Flushing—Pravastatin—atherosclerosis	0.000226	0.0034	CcSEcCtD
Glipizide—Muscle spasms—Simvastatin—atherosclerosis	0.000225	0.0034	CcSEcCtD
Glipizide—Vertigo—Lovastatin—atherosclerosis	0.000225	0.00339	CcSEcCtD
Glipizide—Leukopenia—Lovastatin—atherosclerosis	0.000224	0.00338	CcSEcCtD
Glipizide—Chills—Niacin—atherosclerosis	0.000222	0.00334	CcSEcCtD
Glipizide—Malaise—Ezetimibe—atherosclerosis	0.000221	0.00334	CcSEcCtD
Glipizide—Vision blurred—Simvastatin—atherosclerosis	0.000221	0.00333	CcSEcCtD
Glipizide—Arrhythmia—Niacin—atherosclerosis	0.000221	0.00333	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00022	0.00331	CcSEcCtD
Glipizide—Tremor—Simvastatin—atherosclerosis	0.000219	0.00331	CcSEcCtD
Glipizide—Chills—Pravastatin—atherosclerosis	0.000218	0.00329	CcSEcCtD
Glipizide—Insomnia—Rosuvastatin—atherosclerosis	0.000218	0.00329	CcSEcCtD
Glipizide—Ill-defined disorder—Simvastatin—atherosclerosis	0.000217	0.00328	CcSEcCtD
Glipizide—Arrhythmia—Pravastatin—atherosclerosis	0.000217	0.00328	CcSEcCtD
Glipizide—Paraesthesia—Rosuvastatin—atherosclerosis	0.000217	0.00327	CcSEcCtD
Glipizide—Erythema—Niacin—atherosclerosis	0.000215	0.00324	CcSEcCtD
Glipizide—Myalgia—Lovastatin—atherosclerosis	0.000213	0.00322	CcSEcCtD
Glipizide—Arthralgia—Lovastatin—atherosclerosis	0.000213	0.00322	CcSEcCtD
Glipizide—Anxiety—Lovastatin—atherosclerosis	0.000212	0.0032	CcSEcCtD
Glipizide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000212	0.0032	CcSEcCtD
Glipizide—Hypertension—Ezetimibe—atherosclerosis	0.000212	0.0032	CcSEcCtD
Glipizide—Flatulence—Niacin—atherosclerosis	0.000212	0.0032	CcSEcCtD
Glipizide—Malaise—Simvastatin—atherosclerosis	0.000211	0.00319	CcSEcCtD
Glipizide—Tension—Niacin—atherosclerosis	0.000211	0.00318	CcSEcCtD
Glipizide—Discomfort—Lovastatin—atherosclerosis	0.000211	0.00318	CcSEcCtD
Glipizide—Vertigo—Simvastatin—atherosclerosis	0.00021	0.00317	CcSEcCtD
Glipizide—Leukopenia—Simvastatin—atherosclerosis	0.00021	0.00316	CcSEcCtD
Glipizide—Arthralgia—Ezetimibe—atherosclerosis	0.000209	0.00315	CcSEcCtD
Glipizide—Myalgia—Ezetimibe—atherosclerosis	0.000209	0.00315	CcSEcCtD
Glipizide—Nervousness—Niacin—atherosclerosis	0.000209	0.00315	CcSEcCtD
Glipizide—Flatulence—Pravastatin—atherosclerosis	0.000209	0.00315	CcSEcCtD
Glipizide—Tension—Pravastatin—atherosclerosis	0.000208	0.00313	CcSEcCtD
Glipizide—Muscle spasms—Niacin—atherosclerosis	0.000207	0.00312	CcSEcCtD
Glipizide—Discomfort—Ezetimibe—atherosclerosis	0.000207	0.00312	CcSEcCtD
Glipizide—Constipation—Rosuvastatin—atherosclerosis	0.000206	0.00311	CcSEcCtD
Glipizide—Pain—Rosuvastatin—atherosclerosis	0.000206	0.00311	CcSEcCtD
Glipizide—Confusional state—Lovastatin—atherosclerosis	0.000206	0.00311	CcSEcCtD
Glipizide—Nervousness—Pravastatin—atherosclerosis	0.000206	0.0031	CcSEcCtD
Glipizide—Muscle spasms—Pravastatin—atherosclerosis	0.000204	0.00307	CcSEcCtD
Glipizide—Vision blurred—Niacin—atherosclerosis	0.000203	0.00306	CcSEcCtD
Glipizide—Confusional state—Ezetimibe—atherosclerosis	0.000202	0.00305	CcSEcCtD
Glipizide—Thrombocytopenia—Lovastatin—atherosclerosis	0.0002	0.00302	CcSEcCtD
Glipizide—Vision blurred—Pravastatin—atherosclerosis	0.0002	0.00301	CcSEcCtD
Glipizide—Myalgia—Simvastatin—atherosclerosis	0.000199	0.00301	CcSEcCtD
Glipizide—Arthralgia—Simvastatin—atherosclerosis	0.000199	0.00301	CcSEcCtD
Glipizide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000199	0.003	CcSEcCtD
Glipizide—Anxiety—Simvastatin—atherosclerosis	0.000199	0.003	CcSEcCtD
Glipizide—Tremor—Pravastatin—atherosclerosis	0.000198	0.00299	CcSEcCtD
Glipizide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000197	0.00297	CcSEcCtD
Glipizide—Discomfort—Simvastatin—atherosclerosis	0.000197	0.00297	CcSEcCtD
Glipizide—Ill-defined disorder—Pravastatin—atherosclerosis	0.000196	0.00296	CcSEcCtD
Glipizide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000196	0.00296	CcSEcCtD
Glipizide—Anorexia—Lovastatin—atherosclerosis	0.000195	0.00294	CcSEcCtD
Glipizide—Vertigo—Niacin—atherosclerosis	0.000193	0.00291	CcSEcCtD
Glipizide—Syncope—Niacin—atherosclerosis	0.000193	0.00291	CcSEcCtD
Glipizide—Confusional state—Simvastatin—atherosclerosis	0.000193	0.00291	CcSEcCtD
Glipizide—Leukopenia—Niacin—atherosclerosis	0.000193	0.0029	CcSEcCtD
Glipizide—Urticaria—Rosuvastatin—atherosclerosis	0.000192	0.00289	CcSEcCtD
Glipizide—Oedema—Simvastatin—atherosclerosis	0.000191	0.00288	CcSEcCtD
Glipizide—Malaise—Pravastatin—atherosclerosis	0.000191	0.00288	CcSEcCtD
Glipizide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000191	0.00288	CcSEcCtD
Glipizide—Vertigo—Pravastatin—atherosclerosis	0.00019	0.00287	CcSEcCtD
Glipizide—Leukopenia—Pravastatin—atherosclerosis	0.00019	0.00286	CcSEcCtD
Glipizide—Loss of consciousness—Niacin—atherosclerosis	0.000189	0.00285	CcSEcCtD
Glipizide—Thrombocytopenia—Simvastatin—atherosclerosis	0.000187	0.00282	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000186	0.00281	CcSEcCtD
Glipizide—Insomnia—Lovastatin—atherosclerosis	0.000185	0.00279	CcSEcCtD
Glipizide—Paraesthesia—Lovastatin—atherosclerosis	0.000184	0.00277	CcSEcCtD
Glipizide—Myalgia—Niacin—atherosclerosis	0.000183	0.00276	CcSEcCtD
Glipizide—Arthralgia—Niacin—atherosclerosis	0.000183	0.00276	CcSEcCtD
Glipizide—Hypertension—Pravastatin—atherosclerosis	0.000183	0.00276	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000183	0.00275	CcSEcCtD
Glipizide—Anorexia—Simvastatin—atherosclerosis	0.000182	0.00275	CcSEcCtD
Glipizide—Dyspnoea—Lovastatin—atherosclerosis	0.000182	0.00275	CcSEcCtD
Glipizide—CYP2C9—liver—atherosclerosis	0.000182	0.00971	CbGeAlD
Glipizide—Insomnia—Ezetimibe—atherosclerosis	0.000181	0.00273	CcSEcCtD
Glipizide—Arthralgia—Pravastatin—atherosclerosis	0.00018	0.00272	CcSEcCtD
Glipizide—Myalgia—Pravastatin—atherosclerosis	0.00018	0.00272	CcSEcCtD
Glipizide—Paraesthesia—Ezetimibe—atherosclerosis	0.00018	0.00271	CcSEcCtD
Glipizide—Dyspepsia—Lovastatin—atherosclerosis	0.00018	0.00271	CcSEcCtD
Glipizide—Anxiety—Pravastatin—atherosclerosis	0.00018	0.00271	CcSEcCtD
Glipizide—Dyspnoea—Ezetimibe—atherosclerosis	0.000179	0.0027	CcSEcCtD
Glipizide—Discomfort—Pravastatin—atherosclerosis	0.000178	0.00269	CcSEcCtD
Glipizide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000178	0.00268	CcSEcCtD
Glipizide—Decreased appetite—Lovastatin—atherosclerosis	0.000178	0.00268	CcSEcCtD
Glipizide—Dyspepsia—Ezetimibe—atherosclerosis	0.000176	0.00266	CcSEcCtD
Glipizide—Oedema—Niacin—atherosclerosis	0.000176	0.00265	CcSEcCtD
Glipizide—Pain—Lovastatin—atherosclerosis	0.000175	0.00264	CcSEcCtD
Glipizide—Constipation—Lovastatin—atherosclerosis	0.000175	0.00264	CcSEcCtD
Glipizide—Confusional state—Pravastatin—atherosclerosis	0.000174	0.00263	CcSEcCtD
Glipizide—Decreased appetite—Ezetimibe—atherosclerosis	0.000174	0.00263	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000174	0.00263	CcSEcCtD
Glipizide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000173	0.00261	CcSEcCtD
Glipizide—Asthenia—Rosuvastatin—atherosclerosis	0.000173	0.00261	CcSEcCtD
Glipizide—Insomnia—Simvastatin—atherosclerosis	0.000173	0.00261	CcSEcCtD
Glipizide—Oedema—Pravastatin—atherosclerosis	0.000173	0.00261	CcSEcCtD
Glipizide—Shock—Niacin—atherosclerosis	0.000173	0.0026	CcSEcCtD
Glipizide—Paraesthesia—Simvastatin—atherosclerosis	0.000172	0.00259	CcSEcCtD
Glipizide—Pain—Ezetimibe—atherosclerosis	0.000171	0.00259	CcSEcCtD
Glipizide—Constipation—Ezetimibe—atherosclerosis	0.000171	0.00259	CcSEcCtD
Glipizide—Pruritus—Rosuvastatin—atherosclerosis	0.000171	0.00257	CcSEcCtD
Glipizide—Dyspnoea—Simvastatin—atherosclerosis	0.00017	0.00257	CcSEcCtD
Glipizide—Hyperhidrosis—Niacin—atherosclerosis	0.00017	0.00256	CcSEcCtD
Glipizide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000169	0.00255	CcSEcCtD
Glipizide—Feeling abnormal—Lovastatin—atherosclerosis	0.000168	0.00254	CcSEcCtD
Glipizide—Dyspepsia—Simvastatin—atherosclerosis	0.000168	0.00254	CcSEcCtD
Glipizide—Anorexia—Niacin—atherosclerosis	0.000167	0.00252	CcSEcCtD
Glipizide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000167	0.00252	CcSEcCtD
Glipizide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000167	0.00252	CcSEcCtD
Glipizide—Decreased appetite—Simvastatin—atherosclerosis	0.000166	0.00251	CcSEcCtD
Glipizide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000165	0.00249	CcSEcCtD
Glipizide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000165	0.00249	CcSEcCtD
Glipizide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000165	0.00249	CcSEcCtD
Glipizide—Anorexia—Pravastatin—atherosclerosis	0.000165	0.00248	CcSEcCtD
Glipizide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000164	0.00247	CcSEcCtD
Glipizide—Pain—Simvastatin—atherosclerosis	0.000163	0.00247	CcSEcCtD
Glipizide—Constipation—Simvastatin—atherosclerosis	0.000163	0.00247	CcSEcCtD
Glipizide—Urticaria—Lovastatin—atherosclerosis	0.000162	0.00245	CcSEcCtD
Glipizide—Abdominal pain—Lovastatin—atherosclerosis	0.000162	0.00244	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00016	0.00241	CcSEcCtD
Glipizide—Dizziness—Rosuvastatin—atherosclerosis	0.000159	0.00241	CcSEcCtD
Glipizide—Urticaria—Ezetimibe—atherosclerosis	0.000159	0.0024	CcSEcCtD
Glipizide—Insomnia—Niacin—atherosclerosis	0.000159	0.00239	CcSEcCtD
Glipizide—Abdominal pain—Ezetimibe—atherosclerosis	0.000158	0.00239	CcSEcCtD
Glipizide—Paraesthesia—Niacin—atherosclerosis	0.000158	0.00238	CcSEcCtD
Glipizide—Feeling abnormal—Simvastatin—atherosclerosis	0.000158	0.00238	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000157	0.00237	CcSEcCtD
Glipizide—Dyspnoea—Niacin—atherosclerosis	0.000156	0.00236	CcSEcCtD
Glipizide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000156	0.00236	CcSEcCtD
Glipizide—Insomnia—Pravastatin—atherosclerosis	0.000156	0.00236	CcSEcCtD
Glipizide—Somnolence—Niacin—atherosclerosis	0.000156	0.00235	CcSEcCtD
Glipizide—Gliclazide—ALB—atherosclerosis	0.000156	0.109	CrCbGaD
Glipizide—Paraesthesia—Pravastatin—atherosclerosis	0.000155	0.00234	CcSEcCtD
Glipizide—Dyspepsia—Niacin—atherosclerosis	0.000155	0.00233	CcSEcCtD
Glipizide—Dyspnoea—Pravastatin—atherosclerosis	0.000154	0.00232	CcSEcCtD
Glipizide—Decreased appetite—Niacin—atherosclerosis	0.000153	0.0023	CcSEcCtD
Glipizide—Dyspepsia—Pravastatin—atherosclerosis	0.000152	0.00229	CcSEcCtD
Glipizide—Rash—Rosuvastatin—atherosclerosis	0.000152	0.00229	CcSEcCtD
Glipizide—Dermatitis—Rosuvastatin—atherosclerosis	0.000152	0.00229	CcSEcCtD
Glipizide—Urticaria—Simvastatin—atherosclerosis	0.000152	0.00229	CcSEcCtD
Glipizide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000152	0.00229	CcSEcCtD
Glipizide—Abdominal pain—Simvastatin—atherosclerosis	0.000151	0.00228	CcSEcCtD
Glipizide—Headache—Rosuvastatin—atherosclerosis	0.000151	0.00228	CcSEcCtD
Glipizide—Hypersensitivity—Lovastatin—atherosclerosis	0.000151	0.00227	CcSEcCtD
Glipizide—Decreased appetite—Pravastatin—atherosclerosis	0.00015	0.00227	CcSEcCtD
Glipizide—Pain—Niacin—atherosclerosis	0.00015	0.00226	CcSEcCtD
Glipizide—Constipation—Pravastatin—atherosclerosis	0.000148	0.00223	CcSEcCtD
Glipizide—Pain—Pravastatin—atherosclerosis	0.000148	0.00223	CcSEcCtD
Glipizide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000148	0.00223	CcSEcCtD
Glipizide—Asthenia—Lovastatin—atherosclerosis	0.000147	0.00221	CcSEcCtD
Glipizide—Pruritus—Lovastatin—atherosclerosis	0.000145	0.00218	CcSEcCtD
Glipizide—Asthenia—Ezetimibe—atherosclerosis	0.000144	0.00217	CcSEcCtD
Glipizide—Gastrointestinal pain—Niacin—atherosclerosis	0.000144	0.00216	CcSEcCtD
Glipizide—Nausea—Rosuvastatin—atherosclerosis	0.000143	0.00216	CcSEcCtD
Glipizide—Feeling abnormal—Pravastatin—atherosclerosis	0.000142	0.00215	CcSEcCtD
Glipizide—Pruritus—Ezetimibe—atherosclerosis	0.000142	0.00214	CcSEcCtD
Glipizide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000141	0.00213	CcSEcCtD
Glipizide—Hypersensitivity—Simvastatin—atherosclerosis	0.000141	0.00212	CcSEcCtD
Glipizide—Diarrhoea—Lovastatin—atherosclerosis	0.00014	0.00211	CcSEcCtD
Glipizide—Urticaria—Niacin—atherosclerosis	0.000139	0.0021	CcSEcCtD
Glipizide—Abdominal pain—Niacin—atherosclerosis	0.000139	0.00209	CcSEcCtD
Glipizide—CYP3A4—liver—atherosclerosis	0.000139	0.00741	CbGeAlD
Glipizide—Urticaria—Pravastatin—atherosclerosis	0.000137	0.00207	CcSEcCtD
Glipizide—Asthenia—Simvastatin—atherosclerosis	0.000137	0.00207	CcSEcCtD
Glipizide—Diarrhoea—Ezetimibe—atherosclerosis	0.000137	0.00207	CcSEcCtD
Glipizide—Abdominal pain—Pravastatin—atherosclerosis	0.000137	0.00206	CcSEcCtD
Glipizide—Pruritus—Simvastatin—atherosclerosis	0.000135	0.00204	CcSEcCtD
Glipizide—Dizziness—Lovastatin—atherosclerosis	0.000135	0.00204	CcSEcCtD
Glipizide—Dizziness—Ezetimibe—atherosclerosis	0.000133	0.002	CcSEcCtD
Glipizide—Diarrhoea—Simvastatin—atherosclerosis	0.000131	0.00197	CcSEcCtD
Glipizide—Vomiting—Lovastatin—atherosclerosis	0.00013	0.00196	CcSEcCtD
Glipizide—Hypersensitivity—Niacin—atherosclerosis	0.000129	0.00195	CcSEcCtD
Glipizide—Rash—Lovastatin—atherosclerosis	0.000129	0.00194	CcSEcCtD
Glipizide—Dermatitis—Lovastatin—atherosclerosis	0.000129	0.00194	CcSEcCtD
Glipizide—Headache—Lovastatin—atherosclerosis	0.000128	0.00193	CcSEcCtD
Glipizide—Vomiting—Ezetimibe—atherosclerosis	0.000127	0.00192	CcSEcCtD
Glipizide—Hypersensitivity—Pravastatin—atherosclerosis	0.000127	0.00192	CcSEcCtD
Glipizide—Dizziness—Simvastatin—atherosclerosis	0.000126	0.00191	CcSEcCtD
Glipizide—Rash—Ezetimibe—atherosclerosis	0.000126	0.00191	CcSEcCtD
Glipizide—Dermatitis—Ezetimibe—atherosclerosis	0.000126	0.0019	CcSEcCtD
Glipizide—Asthenia—Niacin—atherosclerosis	0.000126	0.0019	CcSEcCtD
Glipizide—Headache—Ezetimibe—atherosclerosis	0.000126	0.00189	CcSEcCtD
Glipizide—Pruritus—Niacin—atherosclerosis	0.000124	0.00187	CcSEcCtD
Glipizide—Asthenia—Pravastatin—atherosclerosis	0.000124	0.00187	CcSEcCtD
Glipizide—Pruritus—Pravastatin—atherosclerosis	0.000122	0.00184	CcSEcCtD
Glipizide—Vomiting—Simvastatin—atherosclerosis	0.000122	0.00183	CcSEcCtD
Glipizide—Nausea—Lovastatin—atherosclerosis	0.000121	0.00183	CcSEcCtD
Glipizide—Rash—Simvastatin—atherosclerosis	0.000121	0.00182	CcSEcCtD
Glipizide—Dermatitis—Simvastatin—atherosclerosis	0.00012	0.00182	CcSEcCtD
Glipizide—Diarrhoea—Niacin—atherosclerosis	0.00012	0.00181	CcSEcCtD
Glipizide—Headache—Simvastatin—atherosclerosis	0.00012	0.00181	CcSEcCtD
Glipizide—Nausea—Ezetimibe—atherosclerosis	0.000119	0.0018	CcSEcCtD
Glipizide—Diarrhoea—Pravastatin—atherosclerosis	0.000118	0.00178	CcSEcCtD
Glipizide—Dizziness—Niacin—atherosclerosis	0.000116	0.00175	CcSEcCtD
Glipizide—Dizziness—Pravastatin—atherosclerosis	0.000114	0.00172	CcSEcCtD
Glipizide—Nausea—Simvastatin—atherosclerosis	0.000114	0.00171	CcSEcCtD
Glipizide—Vomiting—Niacin—atherosclerosis	0.000112	0.00168	CcSEcCtD
Glipizide—Rash—Niacin—atherosclerosis	0.000111	0.00167	CcSEcCtD
Glipizide—Dermatitis—Niacin—atherosclerosis	0.000111	0.00167	CcSEcCtD
Glipizide—Headache—Niacin—atherosclerosis	0.00011	0.00166	CcSEcCtD
Glipizide—Vomiting—Pravastatin—atherosclerosis	0.00011	0.00166	CcSEcCtD
Glipizide—Rash—Pravastatin—atherosclerosis	0.000109	0.00164	CcSEcCtD
Glipizide—Dermatitis—Pravastatin—atherosclerosis	0.000109	0.00164	CcSEcCtD
Glipizide—Headache—Pravastatin—atherosclerosis	0.000108	0.00163	CcSEcCtD
Glipizide—Nausea—Niacin—atherosclerosis	0.000104	0.00157	CcSEcCtD
Glipizide—Nausea—Pravastatin—atherosclerosis	0.000103	0.00155	CcSEcCtD
Glipizide—Glyburide—ALB—atherosclerosis	8.17e-05	0.0574	CrCbGaD
Glipizide—KCNJ11—Metabolism—APOC3—atherosclerosis	2.13e-05	0.000662	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	2.12e-05	0.000659	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.12e-05	0.000658	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—LDLR—atherosclerosis	2.12e-05	0.000658	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	2.09e-05	0.00065	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOA2—atherosclerosis	2.09e-05	0.000649	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PLA2G2A—atherosclerosis	2.09e-05	0.000649	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALOX5AP—atherosclerosis	2.09e-05	0.000649	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALOX15—atherosclerosis	2.09e-05	0.000649	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CETP—atherosclerosis	2.07e-05	0.000642	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—ESR1—atherosclerosis	2.07e-05	0.000642	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCG5—atherosclerosis	2.06e-05	0.000641	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.06e-05	0.000641	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	2.05e-05	0.000635	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	2.05e-05	0.000635	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—SCARB1—atherosclerosis	2.04e-05	0.000634	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—LEP—atherosclerosis	2.04e-05	0.000633	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	2.01e-05	0.000624	CbGpPWpGaD
Glipizide—PPARG—Metabolism—LPA—atherosclerosis	1.99e-05	0.000619	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—SCARB1—atherosclerosis	1.98e-05	0.000615	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	1.97e-05	0.000613	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—HSPA1B—atherosclerosis	1.94e-05	0.000604	CbGpPWpGaD
Glipizide—PPARG—Metabolism—BGN—atherosclerosis	1.93e-05	0.0006	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—HMGCR—atherosclerosis	1.93e-05	0.000599	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.92e-05	0.000596	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOA5—atherosclerosis	1.91e-05	0.000594	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—ALB—atherosclerosis	1.89e-05	0.000587	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—HMGCR—atherosclerosis	1.87e-05	0.000581	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.86e-05	0.000577	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PLA2G1B—atherosclerosis	1.84e-05	0.000572	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	1.82e-05	0.000566	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.82e-05	0.000565	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.8e-05	0.00056	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.8e-05	0.000559	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALOX5—atherosclerosis	1.78e-05	0.000552	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—INS—atherosclerosis	1.74e-05	0.000541	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—PARP1—atherosclerosis	1.73e-05	0.000538	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	1.73e-05	0.000537	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	1.73e-05	0.000537	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	1.73e-05	0.000537	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	1.73e-05	0.000537	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ABCA1—atherosclerosis	1.72e-05	0.000534	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	1.71e-05	0.00053	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—SERPINE1—atherosclerosis	1.7e-05	0.000528	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ABCA1—atherosclerosis	1.67e-05	0.000518	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	1.65e-05	0.000512	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.64e-05	0.00051	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ESR2—atherosclerosis	1.64e-05	0.00051	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP2—atherosclerosis	1.63e-05	0.000506	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NAMPT—atherosclerosis	1.59e-05	0.000495	CbGpPWpGaD
Glipizide—PPARG—Metabolism—LIPC—atherosclerosis	1.58e-05	0.000492	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	1.58e-05	0.000491	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOC3—atherosclerosis	1.57e-05	0.000489	CbGpPWpGaD
Glipizide—PPARG—Metabolism—LDLR—atherosclerosis	1.56e-05	0.000486	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—IL6—atherosclerosis	1.56e-05	0.000485	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CETP—atherosclerosis	1.53e-05	0.000475	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	1.52e-05	0.000473	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	1.5e-05	0.000467	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—HMOX1—atherosclerosis	1.48e-05	0.000458	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	1.47e-05	0.000456	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SCARB1—atherosclerosis	1.46e-05	0.000455	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—HMOX1—atherosclerosis	1.43e-05	0.000444	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.43e-05	0.000443	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLTP—atherosclerosis	1.41e-05	0.000439	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—APOB—atherosclerosis	1.41e-05	0.000439	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	1.4e-05	0.000434	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HMGCR—atherosclerosis	1.38e-05	0.000429	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	1.38e-05	0.000428	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTM1—atherosclerosis	1.37e-05	0.000427	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APOB—atherosclerosis	1.37e-05	0.000425	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—LPL—atherosclerosis	1.35e-05	0.000419	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTM1—atherosclerosis	1.33e-05	0.000414	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SIRT1—atherosclerosis	1.32e-05	0.00041	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GPX1—atherosclerosis	1.32e-05	0.000409	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	1.31e-05	0.000407	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—LPL—atherosclerosis	1.31e-05	0.000406	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	1.3e-05	0.000404	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	1.29e-05	0.000402	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CD36—atherosclerosis	1.28e-05	0.000398	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GPX1—atherosclerosis	1.28e-05	0.000396	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.26e-05	0.000393	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.25e-05	0.000387	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CD36—atherosclerosis	1.24e-05	0.000386	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCA1—atherosclerosis	1.23e-05	0.000383	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LTA4H—atherosclerosis	1.23e-05	0.000381	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCG8—atherosclerosis	1.23e-05	0.000381	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP9—atherosclerosis	1.22e-05	0.00038	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—MTHFR—atherosclerosis	1.21e-05	0.000377	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NFKB1—atherosclerosis	1.21e-05	0.000376	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.21e-05	0.000376	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARA—atherosclerosis	1.19e-05	0.00037	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—MTHFR—atherosclerosis	1.18e-05	0.000366	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARA—atherosclerosis	1.16e-05	0.000359	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AGT—atherosclerosis	1.15e-05	0.000358	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.14e-05	0.000355	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—APOE—atherosclerosis	1.13e-05	0.000351	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CAV1—atherosclerosis	1.12e-05	0.000348	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AGT—atherosclerosis	1.12e-05	0.000348	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—APOA1—atherosclerosis	1.12e-05	0.000347	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—atherosclerosis	1.1e-05	0.000342	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—PPARA—atherosclerosis	1.1e-05	0.000341	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APOE—atherosclerosis	1.1e-05	0.000341	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—STAT3—atherosclerosis	1.09e-05	0.000338	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CAV1—atherosclerosis	1.09e-05	0.000337	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APOA1—atherosclerosis	1.08e-05	0.000337	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HMOX1—atherosclerosis	1.06e-05	0.000328	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MAPK3—atherosclerosis	1.04e-05	0.000323	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CG—atherosclerosis	1.02e-05	0.000317	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.02e-05	0.000316	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOB—atherosclerosis	1.01e-05	0.000314	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TGFB1—atherosclerosis	1.01e-05	0.000313	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ESR1—atherosclerosis	9.95e-06	0.000309	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	9.92e-06	0.000308	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CG—atherosclerosis	9.9e-06	0.000307	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARG—atherosclerosis	9.85e-06	0.000306	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTM1—atherosclerosis	9.85e-06	0.000306	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCG1—atherosclerosis	9.69e-06	0.000301	CbGpPWpGaD
Glipizide—PPARG—Metabolism—LPL—atherosclerosis	9.67e-06	0.0003	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—INS—atherosclerosis	9.66e-06	0.0003	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARG—atherosclerosis	9.55e-06	0.000297	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GPX1—atherosclerosis	9.43e-06	0.000293	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—atherosclerosis	9.43e-06	0.000293	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—INS—atherosclerosis	9.37e-06	0.000291	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLTP—atherosclerosis	9.32e-06	0.00029	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CD36—atherosclerosis	9.19e-06	0.000285	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LCAT—atherosclerosis	9.11e-06	0.000283	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—FABP4—atherosclerosis	9.11e-06	0.000283	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOA4—atherosclerosis	8.94e-06	0.000278	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALB—atherosclerosis	8.86e-06	0.000275	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP7A1—atherosclerosis	8.79e-06	0.000273	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MTHFR—atherosclerosis	8.7e-06	0.00027	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALB—atherosclerosis	8.59e-06	0.000267	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PPARA—atherosclerosis	8.54e-06	0.000265	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NOS3—atherosclerosis	8.47e-06	0.000263	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	8.37e-06	0.00026	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AGT—atherosclerosis	8.27e-06	0.000257	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NOS3—atherosclerosis	8.21e-06	0.000255	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SERPINE1—atherosclerosis	8.18e-06	0.000254	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP27A1—atherosclerosis	8.12e-06	0.000252	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOE—atherosclerosis	8.1e-06	0.000252	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCG8—atherosclerosis	8.09e-06	0.000251	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LTA4H—atherosclerosis	8.09e-06	0.000251	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CAV1—atherosclerosis	8.03e-06	0.000249	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOA1—atherosclerosis	8.01e-06	0.000249	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	7.99e-06	0.000248	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	7.8e-06	0.000242	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—atherosclerosis	7.75e-06	0.000241	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALOX15—atherosclerosis	7.7e-06	0.000239	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOA2—atherosclerosis	7.7e-06	0.000239	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	7.7e-06	0.000239	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	7.7e-06	0.000239	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6—atherosclerosis	7.61e-06	0.000236	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCG5—atherosclerosis	7.6e-06	0.000236	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	7.6e-06	0.000236	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—atherosclerosis	7.51e-06	0.000233	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LPA—atherosclerosis	7.34e-06	0.000228	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CG—atherosclerosis	7.31e-06	0.000227	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—BGN—atherosclerosis	7.11e-06	0.000221	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	7.06e-06	0.000219	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOA5—atherosclerosis	7.04e-06	0.000219	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—AKT1—atherosclerosis	7.02e-06	0.000218	CbGpPWpGaD
Glipizide—PPARG—Metabolism—INS—atherosclerosis	6.92e-06	0.000215	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.84e-06	0.000212	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	6.78e-06	0.00021	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.7e-06	0.000208	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.64e-06	0.000206	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.62e-06	0.000206	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALOX5—atherosclerosis	6.55e-06	0.000203	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCG1—atherosclerosis	6.39e-06	0.000198	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALB—atherosclerosis	6.35e-06	0.000197	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NOS3—atherosclerosis	6.07e-06	0.000189	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.05e-06	0.000188	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—FABP4—atherosclerosis	6.01e-06	0.000187	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LCAT—atherosclerosis	6.01e-06	0.000187	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOA4—atherosclerosis	5.9e-06	0.000183	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NAMPT—atherosclerosis	5.87e-06	0.000182	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.84e-06	0.000181	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LIPC—atherosclerosis	5.83e-06	0.000181	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOC3—atherosclerosis	5.8e-06	0.00018	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	5.79e-06	0.00018	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LDLR—atherosclerosis	5.76e-06	0.000179	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CETP—atherosclerosis	5.63e-06	0.000175	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—atherosclerosis	5.55e-06	0.000172	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SCARB1—atherosclerosis	5.39e-06	0.000167	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	5.36e-06	0.000166	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MAPK3—atherosclerosis	5.32e-06	0.000165	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.25e-06	0.000163	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMGCR—atherosclerosis	5.09e-06	0.000158	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	5.08e-06	0.000158	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALOX15—atherosclerosis	5.08e-06	0.000158	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	5.08e-06	0.000158	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOA2—atherosclerosis	5.08e-06	0.000158	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCG5—atherosclerosis	5.02e-06	0.000156	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LPA—atherosclerosis	4.84e-06	0.00015	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—BGN—atherosclerosis	4.69e-06	0.000146	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOA5—atherosclerosis	4.64e-06	0.000144	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.59e-06	0.000143	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCA1—atherosclerosis	4.54e-06	0.000141	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	4.47e-06	0.000139	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.32e-06	0.000134	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AKT1—atherosclerosis	3.89e-06	0.000121	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMOX1—atherosclerosis	3.89e-06	0.000121	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.87e-06	0.00012	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LIPC—atherosclerosis	3.85e-06	0.00012	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOC3—atherosclerosis	3.82e-06	0.000119	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LDLR—atherosclerosis	3.8e-06	0.000118	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AKT1—atherosclerosis	3.78e-06	0.000117	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOB—atherosclerosis	3.73e-06	0.000116	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CETP—atherosclerosis	3.71e-06	0.000115	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTM1—atherosclerosis	3.63e-06	0.000113	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—AKT1—atherosclerosis	3.59e-06	0.000111	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LPL—atherosclerosis	3.56e-06	0.000111	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.56e-06	0.00011	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPX1—atherosclerosis	3.47e-06	0.000108	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CD36—atherosclerosis	3.38e-06	0.000105	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.36e-06	0.000104	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTHFR—atherosclerosis	3.21e-06	9.96e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARA—atherosclerosis	3.14e-06	9.77e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AGT—atherosclerosis	3.05e-06	9.46e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.99e-06	9.29e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOE—atherosclerosis	2.98e-06	9.27e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CAV1—atherosclerosis	2.96e-06	9.18e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOA1—atherosclerosis	2.95e-06	9.16e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AKT1—atherosclerosis	2.79e-06	8.67e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.69e-06	8.36e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARG—atherosclerosis	2.6e-06	8.07e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.57e-06	7.97e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—INS—atherosclerosis	2.55e-06	7.92e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOB—atherosclerosis	2.46e-06	7.64e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.39e-06	7.43e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LPL—atherosclerosis	2.35e-06	7.29e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALB—atherosclerosis	2.34e-06	7.26e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPX1—atherosclerosis	2.29e-06	7.11e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NOS3—atherosclerosis	2.24e-06	6.94e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CD36—atherosclerosis	2.23e-06	6.93e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.11e-06	6.57e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARA—atherosclerosis	2.07e-06	6.44e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.04e-06	6.35e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AGT—atherosclerosis	2.01e-06	6.24e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOE—atherosclerosis	1.97e-06	6.11e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CAV1—atherosclerosis	1.95e-06	6.06e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOA1—atherosclerosis	1.95e-06	6.04e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.78e-06	5.52e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARG—atherosclerosis	1.71e-06	5.32e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—INS—atherosclerosis	1.68e-06	5.22e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALB—atherosclerosis	1.54e-06	4.79e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NOS3—atherosclerosis	1.47e-06	4.58e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.35e-06	4.19e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKT1—atherosclerosis	1.03e-06	3.19e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKT1—atherosclerosis	6.78e-07	2.11e-05	CbGpPWpGaD
